Code of Practice for the Clinical Assessment of Licensed Medicinal Products in General Practice
BMJ (British Medical Journal). 1983 Apr 16; 286(6373): 1295-1297.
A code of practice for the clinical assessment of licensed drugs by physicians in general practice has been developed jointly by the British Medical Association, the Royal Society of General Practitioners, and the Association of the British Pharmaceutical Industry. The new code, reproduced in full here, outlines the reasons drug assessments outside hospitals are needed; defines the roles of pharmaceutical firms, ethics committees, and investigators; lists items that must be included in research protocols; and offers guidelines on confidentiality, publication of results, and remuneration. (KIE abstract)
Clinical Ethics; Clinical Ethics Committees; Codes of Ethics; Confidentiality; Drug Industry; Drugs; Ethical Review; Ethics; Ethics Committees; Guidelines; General Practice; Hospitals; Human Experimentation; Industry; Investigators; Patient Care; Physicians; Pharmaceutical Industry; Remuneration; Research; Research Ethics; Review; Standards;
Showing items related by title, author, creator and subject.
Unknown author (1983-04-16)
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use Unknown author (1997)
Draft Commission Directive Laying Down Principles and Detailed Guidelines for Good Clinical Practice as Regards Investigational Medicinal Products for Human Use, as Well as the Requirements for Authorisation of Manufacturing or Importation Of Such Products Unknown author (European Commission, 2004-06-14)This proposed directive redrafts the original European Union clinical trials directive (2001/20/EC) that was developed to govern approval and monitoring of commercially-sponsored clinical research in countries of the ...